Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 201INDUSTRY 17OTHER_GOV 3NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 265Leukemia 183Carcinoma, Non-Small-Cell Lung 168Lymphoma 159Lung Neoplasms 148Prostatic Neoplasms 134Precursor Cell Lymphoblastic Leukemia-Lymphoma 130Ovarian Neoplasms 117Colorectal Neoplasms 115Sarcoma 108Central Nervous System Neoplasms 107Head and Neck Neoplasms 98Leukemia, Myeloid, Acute 95Multiple Myeloma 93Squamous Cell Carcinoma of Head and Neck 83Rectal Neoplasms 77Colonic Neoplasms 71Uterine Cervical Neoplasms 65Neoplasm Metastasis 65Neuroblastoma 64Carcinoma, Ovarian Epithelial 64Brain Neoplasms 64Neoplasms 63Fallopian Tube Neoplasms 62Lymphoma, Large B-Cell, Diffuse 61Astrocytoma 59Melanoma 58Leukemia, Lymphocytic, Chronic, B-Cell 56Burkitt Lymphoma 56Hodgkin Disease 55

Interventions

Trastuzumab 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Neoplastic Cells, Circulating × Clear all
NCT01015625 2024-08-19

POSYTIVE

Austrian Breast & Colorectal Cancer Study Group

Phase NA Completed
90 enrolled 16 charts
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT01548677 2019-03-13

TREAT-CTC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
1,317 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡